ArticleBMC infectious diseases2025
Prevalence and distribution of human papillomavirus genotypes in women living with HIV: a cross-sectional study in Iran.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Epidemiology of Human Papillomavirus in the Middle East and North Africa: A Review of Genotypic Prevalence, Vaccination Challenges, and Non-Cervical Clinical Outcomes.Diseases (Basel, Switzerland) · 2026Review
- A cross-sectional path analysis of the social determinants of STI preventive behaviors: application of the WHO framework.Scientific reports · 2026Article
- Human papillomavirus infection and its association with lung cancer: a case-control study (2011-2019).Iranian journal of microbiology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundWomen living with Human immunodeficiency virus (HIV) have reduced ability to clear human papillomavirus (HPV) infections due to decreased levels of CD4+ T lymphocytes. This study aimed to determine the Prevalence and Distribution of Human Papillomavirus Genotypes in Women Living with HIV: A Cross-Sectional Study in Iran.
methodsEighty women living with HIV participated in this study. HPV DNA was extracted and universal primers (MY09/11 and GP5+/6+) were used in a single polymerase chain reaction (PCR) to detect HPV. Negative samples were re-amplified using GP5+/6+ primers in nested PCR. Finally, HPV-positive samples were genotyped using a Real-Time PCR kit. The data collected in this study were statistically analyzed using GraphPad Prism version 10.4 software.
resultsHPV prevalence among women living with HIV was 76.25%. High-risk (HR) and low-risk (LR)- HPV genotypes were detected in 67.21% and 31.14% of participants, respectively. Multiple HR-HPV infections were found in 71.42% of HPV-positive cases. The most common HR-HPV genotypes were HPV 39 (37.70%) and HPV 52 (36.56%). For LR-HPV genotypes, HPV 44 (13.11%) was the most common type, followed by HPV 6 (3.27%) and HPV 11 (1.63%). Abnormal cervical cytology was significantly associated with HR-HPV infection (14.63%, P-value = 0.026). No significant association was found between HPV prevalence and risk factors such as marital status, education level, age at first sexual intercourse, smoking history, CD4+ T lymphocyte counts or duration of Antiretroviral therapy (ART). Age had a somewhat significant association with the occurrence of HPV infection with a p-value of 0.051.
conclusionsHR-HPV and multiple HR-HPV infections were highly prevalent among women living with HIV in Iran. HPV 39 and 52 being the most common types in our study. Preventive measures like vaccination and regular screening may improve patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.